LRP8 and ovarian carcinoma: This finding was consistent with relevant reports in other cancers, including ovarian cancer (OC) [23], non‐small cell lung cancer (NSCLC) [24], and pancreatic cancer [25], where the malignant progression of tumor cells is often positively regulated by LRP8.